GALLATIN; W. Michael
Patent Applications and Registrations
Patent applications and USPTO patent grants for GALLATIN; W. Michael.The latest application filed is for "therapies for hematologic malignancies".
Company Profile
2.29.19
- GALLATIN; W. Michael - Mercer Island WA
- Gallatin; W. Michael - Seattle WA
Patent Activity
| Patent | Date |
|---|---|
| Therapies For Hematologic Malignancies App 20200368243 - GALLATIN; W. Michael ; et al. | 2020-11-26 |
| Therapies For Hematologic Malignancies App 20190083498 - GALLATIN; W. Michael ; et al. | 2019-03-21 |
| Therapies for hematologic malignancies Grant 10,154,998 - Gallatin , et al. Dec | 2018-12-18 |
| Combination Therapies For Hematologic Malignancies App 20170119771 - GALLATIN; W. Michael ; et al. | 2017-05-04 |
| Therapies For Hematologic Malignancies App 20170112841 - GALLATIN; W. Michael ; et al. | 2017-04-27 |
| Therapies for hematologic malignancies Grant 9,492,449 - Gallatin , et al. November 15, 2 | 2016-11-15 |
| Therapies for hematologic malignancies Grant 9,238,070 - Gallatin , et al. January 19, 2 | 2016-01-19 |
| Combination Therapies For Hematologic Malignancies App 20150196564 - GALLATIN; W. Michael ; et al. | 2015-07-16 |
| Therapies For Hematologic Malignancies App 20140323439 - GALLATIN; W. Michael ; et al. | 2014-10-30 |
| Therapies For Hematologic Malignancies App 20140066386 - GALLATIN; W. Michael ; et al. | 2014-03-06 |
| Therapies For Hematologic Malignancies App 20130071323 - Gallatin; W. Michael ; et al. | 2013-03-21 |
| Combination Therapies For Hematologic Malignancies App 20130064812 - GALLATIN; W. Michael ; et al. | 2013-03-14 |
| Therapies For Hematologic Malignancies App 20100202963 - GALLATIN; W. Michael ; et al. | 2010-08-12 |
| Novel human beta-2 integrin alpha subunit App 20060280739 - Gallatin; W. Michael ; et al. | 2006-12-14 |
| I-CAM related protein App 20050176020 - Gallatin, W. Michael ; et al. | 2005-08-11 |
| I-CAM related protein Grant 6,818,743 - Gallatin , et al. November 16, 2 | 2004-11-16 |
| ICAM-related protein App 20030199423 - Gallatin, W. Michael ; et al. | 2003-10-23 |
| Monoclonal antibodies specific for integrin .alpha.-d subunit Grant 6,620,915 - Gallatin , et al. September 16, 2 | 2003-09-16 |
| Novel human beta2 integrin alpha subunit App 20030077278 - Gallatin, W. Michael ; et al. | 2003-04-24 |
| ICAM-4 materials and methods App 20030068659 - Kilgannon, Patrick D. ; et al. | 2003-04-10 |
| Methods of inhibiting locomotor damage following spinal cord injury with .alpha. D-specific antibodies Grant 6,432,404 - Gallatin , et al. August 13, 2 | 2002-08-13 |
| Novel Human Beta2 Integrin Alpha Subunit App 20020062008 - GALLATIN, W. MICHAEL ; et al. | 2002-05-23 |
| Icam-related protein App 20010029293 - Gallatin, W. Michael ; et al. | 2001-10-11 |
| Modulators of anchoring protein function Grant 6,107,104 - Lockerbie , et al. August 22, 2 | 2000-08-22 |
| Fusion proteins comprising ICAM-R polypeptides and immunoglobulin constant regions Grant 6,100,383 - Gallatin , et al. August 8, 2 | 2000-08-08 |
| Antibodies to ICAM-related protein Grant 6,040,176 - Gallatin , et al. March 21, 2 | 2000-03-21 |
| Modulators of the interaction between ICAM-R and .alpha..sub.d /CD18 Grant 5,880,268 - Gallatin , et al. March 9, 1 | 1999-03-09 |
| Modulators of anchoring protein function Grant 5,871,945 - Lockerbie , et al. February 16, 1 | 1999-02-16 |
| Method for monitoring an inflammatory disease state by detecting circulating ICAM-R Grant 5,869,262 - Gallatin , et al. February 9, 1 | 1999-02-09 |
| ICAM-4 materials and methods Grant 5,852,170 - Kilgannon , et al. December 22, 1 | 1998-12-22 |
| Method of identifying modulators of binding between and VCAM-1 Grant 5,837,478 - Gallatin , et al. November 17, 1 | 1998-11-17 |
| Human .beta.2 integrin .alpha. subunit Grant 5,831,029 - Gallatin , et al. November 3, 1 | 1998-11-03 |
| Human B2 integrin alpha subunit antibodies Grant 5,817,515 - Gallatin , et al. October 6, 1 | 1998-10-06 |
| ICAM-related protein variants Grant 5,811,517 - Gallatin , et al. September 22, 1 | 1998-09-22 |
| Method to identify compounds which modulate ICAM-related protein interactions Grant 5,773,218 - Gallatin , et al. June 30, 1 | 1998-06-30 |
| Anti-ICAM-4 antibodies and hybridomas Grant 5,773,293 - Kilgannon , et al. June 30, 1 | 1998-06-30 |
| Neuron-specific ICAM-4 promoter Grant 5,753,502 - Kilgannon , et al. May 19, 1 | 1998-05-19 |
| Calcineurin inhibitory compounds and anchoring protein to induce IL-2 gene expression Grant 5,744,354 - Lockerbie , et al. April 28, 1 | 1998-04-28 |
| Human .beta..sub.2 integrin .alpha.subunit Grant 5,728,533 - Gallatin , et al. March 17, 1 | 1998-03-17 |
| ICAM-related protein Grant 5,663,293 - Gallatin , et al. September 2, 1 | 1997-09-02 |
| Assay for 1-CAM related protein expression Grant 5,532,127 - Gallatin , et al. July 2, 1 | 1996-07-02 |
| DNA encoding I-CAM related protein Grant 5,525,487 - Gallatin , et al. June 11, 1 | 1996-06-11 |
| Lymphocyte adhesion receptor for high endothelium, CD44 Grant 5,504,194 - St. John , et al. April 2, 1 | 1996-04-02 |
| Human .beta..sub.2 integrin .alpha. subunit Grant 5,470,953 - Gallatin , et al. November 28, 1 | 1995-11-28 |
| DNA sequence encoding a lymphocyte adhesion receptor for high endothelium Grant 5,002,873 - St. John , et al. March 26, 1 | 1991-03-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 